Life Science and Healthcare
Manchester has come a long way since Rutherford first split the atom, Alan Turing lectured here and even since Andre Geim and Konstantin Novoselo peeled their first layer of graphene. We have pioneered new treatments such as the Bionic Eye and Proton Beam Therapy at the Christie and have continued to innovate ever since. Home to a world leading research and development assets like the Manchester Cancer Research Centre and UK Biobank, the city-region continues to be at the forefront of innovative treatment to revolutionise patient care.
As the first UK city to have devolved control of its £6 billion health and social care budget, the region has developed a more streamlined innovation adoption pathway overseen by Health Innovation Manchester, with the aim of delivering new health and social care innovations at pace and scale representing a unique opportunity to life science companies.
The city-region is digitally focused and is home to the first fully e-enabled NHS Trust, married with Greater Manchester's digital capabilities and infrastructure, we provide investors with an experienced digital testbed and expertise to call upon. We have a deep concentration of proteogenomic expertise – a major factor in Qiagen’s decision to establish here and has been recognised by the UK government to receive a share of the £100 million promised as part of the Innovation Accelerator.
The Department for International Trade has acknowledged Greater Manchester's potential in their High Potential Opportunity (HPO) programme with Greater Manchester and Cheshire becoming the first region to share a HPO for 'Diagnostics to support Healthy Ageing'. This designation brings together our ambitions for the region as a place for residents to grow up, get on and grow old and highlights our ability to bring innovative companies to market in a dynamic and open ecosystem.
The region’s clinical and academic excellence are the reasons why businesses such as Qiagen, Kratos Analytical, Hologic, Yourgene Health, E-Lucid, TruePill, Allscripts, Affinity Biomarkers Lab, Lumira Dx, Lonza, Proteintech Group and Chiesi have a presence here.
Life Science and Healthcare Factsheet
Manchester- A City of Firsts in Life Science and HealthcareDownload
Richard Fountain Business Development Manager – Life Sciences
- 7 minutes
Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General and the UK’s leading property provider dedicated to the growth of the science and technology sector, has…
- 7 minutes
The new design for Therme Manchester has received approval from Trafford Council’s planning committee. The updated scheme features a pavilion-style concept immersed and enveloped in a…
- 6 minutes
Progressive plans for the next phase of Manchester Science Park ’s masterplan development have been approved by Manchester City Council . The scheme will see Bruntwood SciTech, a 50:50 joint…